Loading fund overlap…
16 of 140 unique stocks in common · Jaccard: 11.4%
A weighted portfolio overlap of 20.71% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹20.71 is allocated to the exact same companies at the same relative proportions. The schemes share 16 common holdings.
The largest overlapping asset in their portfolios is Reliance Industries, which commands a weight of 5.41% in ICICI Prudential Large Cap Fund and 8.46% in Tata Nifty500 Multicap India Manufacturing 50-30-20 Index Fund. Holding both schemes increases your concentration in Reliance Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in ICICI | in Tata |
|---|---|---|
| Reliance IndustriesPetroleum Products | 5.41% | 8.46% |
| Maruti Suzuki IndiaAutomobiles | 3.55% | 3.65% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 2.65% | 4.04% |
| Mahindra & MahindraAutomobiles | 2.34% | 5.77% |
| Hero MotoCorpAutomobiles | 1.59% | 1.98% |
| Hindustan AeronauticsAerospace & Defense | 1.11% | 1.73% |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 0.87% | 1.68% |
| Eicher MotorsAutomobiles | 0.62% | 2.09% |
| Page IndustriesTextiles & Apparels | 0.62% | 0.75% |
| Tata SteelFerrous Metals | 0.43% | 3.64% |
| Tata Motors Passenger VehiclesAutomobiles | 0.36% | 1.75% |
| CiplaPharmaceuticals & Biotechnology | 0.33% | 1.67% |
| Havells IndiaConsumer Durables | 0.28% | 0.92% |
| Supreme IndustriesIndustrial Products | 0.21% | 0.71% |
| LupinPharmaceuticals & Biotechnology | 0.19% | 1.71% |
| Bajaj AutoAutomobiles | 0.17% | 2.46% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.